Improvements should be made cautiously along with the frequency of blood glucose monitoring should be elevated. Changes in concomitant oral antidiabetic treatment could be needed. Short SAFETY Assertion: Failure to make use of the Dexcom Continual Glucose Monitoring Program and its components in accordance with the instructions for use https://carls470rle6.oneworldwiki.com/user